KeyCorp Lowers Tenet Healthcare (NYSE:THC) Price Target to $225.00

Key Points

• KeyCorp lowered its price target on Tenet Healthcare to $225 from $250 but kept an "overweight" rating, implying roughly a 20.6% upside from the current share price.
• Most analysts remain positive—several firms have raised targets recently (UBS, Truist, Jefferies, Barclays, Leerink), leaving a consensus average price target of $249.17 and an overall "Moderate Buy" rating.
• Tenet beat Q1 EPS ($4.82 vs. $4.21 est.) and is deploying about $125M to acquire ambulatory surgery centers to boost higher‑margin outpatient revenue, though revenue slightly missed estimates and FY 2026 EPS guidance was set at $16.38–$18.68.

Tenet Healthcare (NYSE:THC - Get Free Report) had its price objective lowered by investment analysts at KeyCorp from $250.00 to $225.00 in a report released on Friday,Benzinga reports. The brokerage presently has an "overweight" rating on the stock. KeyCorp's price target suggests a potential upside of 20.61% from the company's current price.

THC has been the topic of a number of other research reports. Jefferies Financial Group raised their target price on Tenet Healthcare from $250.00 to $265.00 and gave the stock a "buy" rating in a report on Thursday, February 12th. Truist Financial raised their price target on Tenet Healthcare from $240.00 to $270.00 and gave the stock a "buy" rating in a research report on Tuesday, February 17th. Barclays raised their price target on Tenet Healthcare from $240.00 to $257.00 and gave the stock an "overweight" rating in a research report on Friday, February 13th. Leerink Partners raised their price target on Tenet Healthcare from $255.00 to $264.00 and gave the stock an "outperform" rating in a research report on Friday, February 20th. Finally, UBS Group raised their price target on Tenet Healthcare from $260.00 to $288.00 and gave the stock a "buy" rating in a research report on Thursday, February 12th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $249.17.

Tenet Healthcare Price Performance

Shares of THC stock traded up $9.44 during trading hours on Friday, hitting $186.56. 108,548 shares of the company's stock were exchanged, compared to its average volume of 1,119,912. The stock's 50-day moving average is $207.31 and its 200-day moving average is $204.17. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The stock has a market cap of $16.34 billion, a price-to-earnings ratio of 12.07, a price-to-earnings-growth ratio of 1.35 and a beta of 1.49. Tenet Healthcare has a 52 week low of $145.27 and a 52 week high of $247.21.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The company had revenue of $5.37 billion for the quarter, compared to analysts' expectations of $5.39 billion. During the same quarter in the prior year, the business earned $4.36 earnings per share. The business's revenue for the quarter was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, research analysts forecast that Tenet Healthcare will post 17.31 EPS for the current year.

Insiders Place Their Bets

In other Tenet Healthcare news, EVP Thomas W. Arnst sold 24,000 shares of the business's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the transaction, the executive vice president owned 8,012 shares of the company's stock, valued at $1,875,128.48. The trade was a 74.97% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Paola M. Arbour sold 6,500 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total value of $1,549,795.00. Following the transaction, the executive vice president owned 29,291 shares of the company's stock, valued at $6,983,853.13. This represents a 18.16% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 46,517 shares of company stock valued at $10,943,111 in the last 90 days. 0.81% of the stock is currently owned by insiders.

Institutional Trading of Tenet Healthcare

A number of institutional investors have recently modified their holdings of the stock. Wedmont Private Capital grew its stake in shares of Tenet Healthcare by 2.5% in the 4th quarter. Wedmont Private Capital now owns 2,088 shares of the company's stock worth $422,000 after buying an additional 50 shares during the last quarter. Baron Wealth Management LLC grew its stake in shares of Tenet Healthcare by 4.8% in the 4th quarter. Baron Wealth Management LLC now owns 1,142 shares of the company's stock worth $227,000 after buying an additional 52 shares during the last quarter. Sagespring Wealth Partners LLC lifted its position in Tenet Healthcare by 3.6% in the 4th quarter. Sagespring Wealth Partners LLC now owns 1,573 shares of the company's stock valued at $313,000 after acquiring an additional 55 shares in the last quarter. Quadrant Capital Group LLC lifted its position in Tenet Healthcare by 0.7% in the 4th quarter. Quadrant Capital Group LLC now owns 8,134 shares of the company's stock valued at $1,616,000 after acquiring an additional 58 shares in the last quarter. Finally, Syon Capital LLC lifted its position in Tenet Healthcare by 5.3% in the 4th quarter. Syon Capital LLC now owns 1,254 shares of the company's stock valued at $249,000 after acquiring an additional 63 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors.

Tenet Healthcare News Roundup

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Q1 earnings beat consensus — Tenet reported $4.82 EPS vs. ~$4.21 expected, beating estimates and demonstrating solid profitability and margin control. Zacks: Q1 Earnings Top Estimates
• Positive Sentiment: Big push into ASCs — Tenet deployed ~$125M to acquire seven ASCs in Q1, signaling a strategic shift toward higher-margin outpatient care that should support long-term revenue mix improvement and margin expansion. Becker's ASC: $125M on 7 ASC acquisitions
• Positive Sentiment: ASC acuity and service expansion — Tenet is seeing double-digit joint replacement growth and runs 150+ robotic surgery programs, which supports higher-acuity outpatient volume and revenue per case over time. Becker's ASC: ASC acuity push paying off
• Positive Sentiment: Management execution praised — Management attributed navigating Q1 volume variability to disciplined operations, which investors view as supportive of margins and cash flow. FierceHealthcare: Met Q1's volume curveballs
• Neutral Sentiment: FY‑2026 guidance provided — Tenet issued EPS guidance of roughly $16.38–$18.68 (consensus ~17.22) and revenue guidance centered near consensus, leaving room for interpretation but giving investors forward visibility. Yahoo Finance: Q1 2026 Earnings Call Summary
• Negative Sentiment: Revenue slight miss and admissions/payer-mix headwinds — Revenue came in a touch below estimates (~$5.37B vs. $5.39B expected) and management cited an unfavorable admissions mix and external disruptions that weighed on top-line performance. Benzinga: Blames admissions mix for soft Q1 sales

About Tenet Healthcare

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.